Collectively, such findings are understandable if defective intra-islet glucagon action contributes to a characteristic loss of first-phase GSIS in the intravenous glucose tolerance test that is diagnostic of T2D in the clinical setting (5). Here, GCG is linked to type 2 diabetes mellitus.